Bust Then Boom
Meet Gene Dantsker:
Dr. Gene Dantsker is President and Chief Operating Officer of EvoNexus. He has been involved with EvoNexus since its founding as selection committee member, mentor to numerous portfolio companies, Executive-in-Residence and most recently Chief MedTech Officer. Gene is a seasoned entrepreneur, board member, advisor, operational executive and angel investor. He holds B.S. degrees in Physics and Mathematics from the University of Maryland, M.A. and Ph.D. in Physics from the University of California at Berkeley, and an MBA from San Diego State University, where he was class valedictorian. He is an inventor on over 60 issued patents.
Key Insights:
Gene Dantsker works at EvoNexus helping entrepreneurs turn good ideas into commercially-viable companies.
● Picking Winners. Because they are selective in their application process, EvoNexus has produced very positive results, with total capital raised approaching $1.7 billion for the 260 companies they’ve incubated.
● Market Timing. Gene suggests that it is actually a good time for startups in general right now, as opposed to even six months ago.
● Diversity is Profitable. Offering examples like pre-diabetes, hypertension, or particular forms of therapeutics or diagnostics, Gene suggests that different strategic plans can be used to find and deliver healthcare to diverse markets.
This episode is hosted by Rick Lemoine. He is the Chief Medical Information Officer for Sharp HealthCare.
Relevant Links:
